These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22294773)

  • 1. A review of the genetic background and tumour profiling in familial colorectal cancer.
    van Wezel T; Middeldorp A; Wijnen JT; Morreau H
    Mutagenesis; 2012 Mar; 27(2):239-45. PubMed ID: 22294773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer.
    Middeldorp A; Jagmohan-Changur SC; van der Klift HM; van Puijenbroek M; Houwing-Duistermaat JJ; Webb E; Houlston R; Tops C; Vasen HF; Devilee P; Morreau H; van Wezel T; Wijnen J
    Genes Chromosomes Cancer; 2010 Jun; 49(6):539-48. PubMed ID: 20222047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial colorectal cancer syndrome X.
    Lipkin SM; Afrasiabi K
    Semin Oncol; 2007 Oct; 34(5):425-7. PubMed ID: 17920898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary cancers after sporadic and familial colorectal cancer.
    Hemminki K; Li X; Dong C
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):793-8. PubMed ID: 11440965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing hereditary colorectal cancer.
    Gallagher DJ; Smith JD; Offit K; Stadler ZK
    Clin Colorectal Cancer; 2010 Oct; 9(4):205-11. PubMed ID: 20920991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and tumor characteristics may raise clinicians' awareness of familial colorectal cancer: a Norwegian population-based study.
    Tranø G; Wasmuth H; Sjursen W; Vatten L
    Scand J Gastroenterol; 2011 Oct; 46(10):1236-42. PubMed ID: 21679123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer.
    Ankathil R; Jyothish B; Madhavan J; Nair MK
    J Exp Clin Cancer Res; 1999 Mar; 18(1):33-7. PubMed ID: 10374674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.
    Kim MY; Yim SH; Kwon MS; Kim TM; Shin SH; Kang HM; Lee C; Chung YJ
    Gastroenterology; 2006 Dec; 131(6):1913-24. PubMed ID: 17087931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial colorectal cancer: a concept revisited.
    Martellucci J; Civitelli S; Dhamo A; Tanzini G
    Colorectal Dis; 2009 Feb; 11(2):133-7. PubMed ID: 18462235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms.
    Venkatachalam R; Ligtenberg MJ; Hoogerbrugge N; Geurts van Kessel A; Kuiper RP
    Cytogenet Genome Res; 2008; 123(1-4):188-94. PubMed ID: 19287155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic risk factors in colorectal cancer.
    Bonaïti-Pellié C
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S27-32. PubMed ID: 10772415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital genetic instability in colorectal carcinomas.
    Svendsen LB
    Dan Med Bull; 1993 Nov; 40(5):546-56. PubMed ID: 8299399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of osteoprotegerin expression in human colorectal cancer.
    Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
    Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARLTS1 variants and risk of colorectal cancer.
    Frank B; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Lett; 2006 Dec; 244(2):172-5. PubMed ID: 16488076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
    Drucker L; Stackievitz R; Shpitz B; Yarkoni S
    Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.
    Kleibl Z; Havranek O; Hlavata I; Novotny J; Sevcik J; Pohlreich P; Soucek P
    Eur J Cancer; 2009 Mar; 45(4):618-24. PubMed ID: 18996005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colon carcinoma: molecular diagnosis and therapy].
    Blum HE
    Praxis (Bern 1994); 1997 Sep; 86(39):1504-9. PubMed ID: 9411670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.